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A B S T R A C T
It has been two decades since the discovery of the most mutagenic human DNA polymerase, polymerase iota
(Polι). Since then, the biochemical activity of this translesion synthesis (TLS) enzyme has been extensively
explored, mostly through in vitro experiments, with some insight into its cellular activity. Polι is one of four
members of the Y-family of polymerases, which are the best characterized DNA damage-tolerant polymerases
involved in TLS. Polι shares some common Y-family features, including low catalytic eﬃciency and processivity,
high inﬁdelity, the ability to bypass some DNA lesions, and a deﬁciency in 3′→5′ exonucleolytic proofreading.
However, Polι exhibits numerous properties unique among the Y-family enzymes. Polι has an unusual catalytic
pocket structure and prefers Hoogsteen over Watson-Crick pairing, and its replication ﬁdelity strongly depends
on the template; further, it prefers Mn2+ ions rather than Mg2+ as catalytic activators. In addition to its
polymerase activity, Polι possesses also 5′-deoxyribose phosphate (dRP) lyase activity, and its ability to parti-
cipate in base excision repair has been shown. As a highly error-prone polymerase, its regulation is crucial and
mostly involves posttranslational modiﬁcations and protein-protein interactions. The upregulation and down-
regulation of Polι are correlated with diﬀerent types of cancer and suggestions regarding the possible function of
this polymerase have emerged from studies of various cancer lines. Nonetheless, after twenty years of research,
the biological function of Polι certainly remains unresolved.
1. Introduction
DNA polymerase iota (Polι), originally named as RAD30B, was
discovered as the second human homolog of yeast Rad30 during a surge
in translesion synthesis (TLS) polymerase discovery at the turn of the
century [1]; its translesion activity was conﬁrmed a year later [2–4].
Polι, together with polymerases eta (Polη), kappa (Polκ), and Rev1,
belongs to the Y-family of polymerases, which are best recognized for
their translesion synthesis (TLS) activity [5]. During TLS, a high ﬁdelity
replicase that is blocked by a DNA lesion is replaced by a TLS enzyme
that, by itself or with help from another polymerase, introduces nu-
cleotides opposite the lesion in the template and extends it to the point
at which the replicase can take over (reviewed in [6–7]). Recruitment
of TLS polymerases to blocked replication forks must be strictly con-
trolled because Y-family polymerases, with their variable nucleotide
selection and lack of 3′→5′ exonuclease activity, are highly error-prone
when copying undamaged templates. Regulation of Y-family poly-
merases involves posttranslational modiﬁcations of various proteins
and protein-protein interactions. A major regulatory role is played by
the processivity replication factor PCNA, which undergoes mono-
ubiquitination at K164 in response to blocked replication fork pro-
gression [8]. This monoubiquitination strengthens the interaction of
PCNA with Y-family polymerases by providing an additional binding
site, which helps initiate TLS [9].
Polι has typically been thought of as an error-prone backup for Polη
based on the biochemical characterization of Polι, the hypermutable
nature of xeroderma pigmentosum variant (XPV) cells lacking Polη, and
the continued diﬃculties in identifying speciﬁc function for Polι.
However, the unusual features of Polι and the increasing number of
putative functions and known regulation of Polι suggest a speciﬁc, in-
dependent cellular role for Polι.
Despite multiple reviews on translesion synthesis and Y-family
polymerases, including Polι, there are few articles focusing solely on
Polι [7,10–21].
The aim of this review is to summarize ﬁndings about Polι from the
last twenty years, especially those involving Polι expression and reg-
ulation, its ability or inability to bypass certain lesions, which are in-
formation that may help determine the cellular function of Polι.
2. Polι and its homologs
In humans, the POLI gene is localized on chromosome 18q21.2. Polι
is evolutionarily conserved and its homologs are present in many or-
ganisms. Unlike other Y-family polymerases, homologs of Polι have not
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been identiﬁed in prokaryotes, yeast, or nematodes. However, Polι is
present in a variety of other fungi excluding yeast, including members
of both the Ascomycota and Basidiomycota phyla. Most of plants seem
to lack POLI homologs. Nonetheless, sequences encoding Polι have been
found in seven species of green algae and the spikemoss Selaginella
moellendorﬃi, which belongs to an ancient group of plants. It has been
speculated that POLI may have resulted from duplication of POLH
(encoding Polη) shortly before the divergence of insects [22], as the
enzymatic properties of Drosophila melanogaster Polι more closely re-
semble those of Saccharomyces cerevisiae Polη than human Polι [23]. In
addition, orthologs of POLI gene have been identiﬁed in some mollusks
and echinoderms, including the paciﬁc oyster Crassostrea gigas and the
purple sea urchin Strongylocentrotus purpuratus, which show 40-65%
identity with human POLI. Surprisingly, Polι was not identiﬁed in
chicken cells and it was previously thought that birds are deﬁcient in
this polymerase; however, additional genomic sequencing has revealed
Polι in 50 species of birds. Nonetheless, the lack of Polι in certain
species is intriguing and awaits explanation. Additionally, the analysis
of crude tissue extracts from various vertebrates, including ﬁsh, am-
phibians, reptiles, birds, and mammals, demonstrated that the distinct
Polι activity of incorporating G opposite template T only occurs in
mammalian tissues [24]. This may indicate that in mammals, Polι
possesses speciﬁc enzymatic activity correlated with structural changes
in its active center, and L62 residue in human Polι appears responsible
for this particular enzymatic property [24].
Polη is the closest paralog of Polι in mammalian cells, however, the
Y family polymerases Polκ and Rev1 also share some homology with
Polι, particularly within the catalytic domain. Despite high sequence
similarity, overexpressed Polι is not able to complement defects in XPV
cells caused by Polη loss [25].
3. Polι localization and tissue speciﬁcity
Human Polι is roughly 80-kDa protein consisting of 715 amino acids
(GenBank Accession number AF140501.1). Some reference sequences
(e.g. NM_007195.2) describe Polι as a 740 amino acid protein with an
additional 25 residues at the N-terminus, however, experimental evi-
dence suggests that the 715 amino acid form of Polι is the predominant
isoform [26].
Polι is mainly a nuclear protein, although it can also localize to
cytoplasmic bodies (www.proteinatlas.org, [27]). Polι possesses a non-
classical nuclear localization signal that loosely maps to amino acids
219 to 451, with the region formed by amino acids 400-451 potentially
being highly important for nuclear localization [25]. Polι is expressed at
low or medium levels in various tissues and is most highly expressed in
the testes [1] and thyroid glands at both the RNA and protein levels
(www.proteinatlas.org, [28]). This is supported by biochemical ana-
lyses of crude cell extracts of various mammalian tissues, in which Polι
activity was detected in testes and brain extracts [24]. Interestingly,
Polι activity varies signiﬁcantly during development, as high levels of
Polι activity detected in extracts of most embryonic mouse organs de-
creased sharply after birth [29]. Moreover, varying levels of Polι ex-
pression have been observed in diﬀerent types of tumors [30–34].
Particularly tight correlations between Polι expression and cancer in-
cidence are observed for esophageal squamous cell carcinoma (ESCC)
tissues and Polι is a proposed biomarker for the metastasis of ESCC
tumors [35–36].
4. Polι structure and domains
Despite a lack of sequence homology, Polι, similarly to all DNA
polymerases, topologically resembles a right hand with ﬁngers (38-98
aa), thumb (225-288 aa), and palm (25-37 and 99-224 aa) subdomains
that form a catalytic active site that is highly conserved among Y-family
polymerases and is N-terminally located [37]. Similar to other Y-family
polymerases and in contrast to classical replicases, Polι lacks a 3′→5′
exonuclease domain and possesses an additional sub-domain at the C-
terminus of the catalytic core named the “little ﬁnger” (LF), “poly-
merase associated domain” (PAD), or “wrist” (298-414 aa) (Fig. 1) [11].
LF domains share little sequence identity across the Y-polymerase fa-
mily and play important roles in deﬁning the unique biochemical
characteristics of particular Y enzymes [38]. Compared to other Y-fa-
mily polymerases, the LF of Polι has greater mobility and may be re-
sponsible for the enzyme’s low processivity [39]. In general, for Y-fa-
mily members, short ﬁngers and thumb domains create a spacious and
ﬂexible catalytic pocket that enables tolerance of various damaged
bases in templates and provides limited stringency in selection of up-
coming nucleotides, causing increased inﬁdelity when copying un-
damaged templates. Compared to other Y-family polymerases, the ac-
tive site of Polι is rather narrow, which stimulates formation of non-
canonical interactions between nucleotides. The palm domain, con-
taining catalytic residues D34, D126, and E127 located at the bottom of
the DNA binding groove, and the ﬁngers domain that lays over the
template base and the incoming nucleotide are critical for Polι activity
[40–41]. The thumb domain makes a few contacts with the minor
groove of DNA, while the LF domain makes multiple contacts with the
major groove of DNA [18,41]. Additionally, the Y39 residue likely helps
discriminate between ribo- and deoxyribonucleotides [18].
The N-terminal catalytic core of Polι contains two partly over-
lapping catalytic domains. The domain with DNA polymerase activity is
located between 24-414 aa while the domain with dRP lyase activity is
located between 79-445 aa [43]. In addition, the N-terminal region
containing residues 1-78 may indirectly inﬂuence dRP lyase activity
and residues Q59 and K60 may stabilize DNA in the correct orientation
or help generate the protein conformation required for cleavage of dRP-
groups [44].
The N-terminal, catalytic half of Y family polymerases appears to
have a well-deﬁned structure while the C-terminal half is predicted to
mostly contain disordered regions except for short regions corre-
sponding to protein binding domains [45], including a PIP box (PCNA-
interacting peptide, 420-427 aa) [46–47], RIR (Rev1-interacting region,
539-554 aa) [48] and two UBMs (ubiquitin-binding motifs, 496-524
and 681-709 aa) [37,49–50] (Fig. 2). These C-terminal protein binding
domains are involved in protein-protein interactions with important
regulatory roles.
5. Biochemical properties of Polι
Like other Y family polymerases, Polι lacks 3′→5′ exonuclease ac-
tivity [2–3]. However, this lack of proofreading activity does not fully
Fig. 1. Crystal structure of the catalytic domain of human Polι in a ternary
complex with a T-G mismatch. Domains are color-coded as follows: palm (red),
ﬁngers (blue), thumb (green), LF (grey) (PDB ID code 3GV8) [42].
J. McIntyre DNA Repair 86 (2020) 102753
2
explain the high and extremely template-dependent inﬁdelity of Polι
with undamaged DNA. Opposite template A Polι is the most accurate
and misincorporates A, G, or C with a frequency of 10-4, which is
moderate for Y- family polymerases. Opposite template G and C Polι is
less accurate and misincorporates roughly one in 100-1000 nucleotides.
Interestingly, the ﬁdelity of Polι is lost opposite template T, with Polι
exhibiting 3-10-fold higher incorporation of incorrect G compared to
correct A [2–4]. This remarkable property is speciﬁc for mammalian
Polι, as Polι from Drosophila melanogaster typically incorporates A op-
posite template T [23].
These dramatic diﬀerences in the eﬃciency and error frequency of
Polι depending on the speciﬁc template base were initially explained by
Washington et al. based on pre-steady-state kinetic analysis [51]. They
showed that opposite template A, the correct nucleotide is preferred
due to tighter binding and faster incorporation, and opposite template T
the G misincorporation occurs due to tighter binding of G. In addition,
based on structural analysis, interactions between the ﬁngers and LF
domains were suggested to be responsible for promoting G mismatches
with T [42]. Finally, detailed analysis of the crystal structure of the Polι
catalytic domain reveals that unlike other Y-family members, Polι binds
template bases in a syn conformation. This induces formation of
Hoogsteen, rather than Watson-Crick base pairing with the incoming
nucleotide and explains the high ﬁdelity and eﬃciency of Polι opposite
template A and low ﬁdelity and eﬃciency opposite template T [52].
Additionally, Hoogsteen base-pairing provides Polι with the ability to
incorporate nucleotides opposite certain DNA lesions [53]. Interest-
ingly, based on crystallographic analysis, it appears that upon dNTP
binding, Polι does not undergo a conformational change, but instead, its
active site and the incoming nucleotide, cause template A and G bases
to convert from the anti to syn conformation. This is in contrast to re-
plicative polymerases that undergo conformational changes upon dNTP
binding [40]. Interestingly, contradictory evidence indicates the pre-
sence of wobble base pairing rather than Hoogsteen pairing [54]. Al-
ternatively, it has been suggested that depending on local conditions,
Polι may utilize strategies including Watson-Crick, Hoogsteen, or other
possible base pairing mechanisms to bypass bulky lesions [55].
Based on evolutionary analysis of Polι sequences from various or-
ganisms, Makarova et al. hypothesized that the substitution of L62 to
isoleucine is responsible for decreases in Polι accuracy [24]. In addi-
tion, further analysis of Polι sequences indicates that Y39A and Q59A
substitutions signiﬁcantly reduce the catalytic activity of Polι, but in-
crease its ﬁdelity [56].
Another factor that considerably inﬂuences the enzymatic proper-
ties of Polι is the type of divalent cation for catalysis activation. In vitro
experiments demonstrate that Polι can synthesize DNA using Mg2+, the
most abundant divalent cation and general replicative polymerase co-
factor, but does so at a much narrower concentration range of 50-250
μM compared to other polymerases [57]. Interestingly, unique among
Y-family polymerases, Polι exhibits a strong preference for Mn2+ over
Mg2+ as a catalytic activator and has an optimal Mn2+ concentration of
75 μM [57]. Such preference is supported by structural and pre-steady-
state kinetic studies, which show that Mn2+ causes 2-3 times more
eﬃcient Polι catalysis compared to Mg2+ [58]. Additionally, cell
extracts from various mouse organs all show Polι activity when Mn2+ is
the cofactor while using Mg2+ only triggered Polι activity in testes and
brain cell extracts [59]. Mn2+ use also reduces the ﬁdelity of Polι op-
posite template A but increases its ﬁdelity by 3-5-fold opposite template
T. Additionally, Mn2+ helps stimulate lesion bypass by Polι [57].
However, Polι activity is eﬃciently inhibited by the divalent cations
Cd2+ and Zn2+ [60].
Polι shows relatively low processivity, and in general, can in-
corporate only 2-3 nucleotides once bound [2]. However, in vitro ana-
lysis using diﬀerent DNA substrates shows that Polι robustly ﬁlls 1-nt
gaps and performs limited strand displacement, although Polι was un-
able to initiate synthesis with a nick-containing template [61]. Ad-
ditionally, incorporation of nucleotides by Polι at the end of DNA is
template-dependent and is highly error-prone. Polι can also extend
single and tandem mispairs, and is especially eﬃcient in extending
tandem mispairs that occur within a short gap [61]. Polι is able to ex-
tend all 12 types of mispairs, but the eﬃciency of this extension de-
pends on both the sequence at the 3′ end of the primer and the template
context. In general, extensions from matched and mismatched pairs are
most eﬃcient and accurate when A is the next template base and are
least eﬃcient and accurate when T is the next template base. Zhang
et al. observed that Polι, when opposite template T frequently aborts
DNA synthesis in a so-called “T stop” [3]. One exception to this rule is
the extension of a G:T mispair, which is more often correctly extended
when T is in the template, thus ﬁxing mutations in a TT template [62].
In addition to its polymerase activity, Polι also exhibits intrinsic 5’-
deoxyribose (dRP) lyase activity that catalyzes excision of 5’-dRP
groups from DNA during base excision repair (BER) [63]. The Polι dRP
lyase domain maps to the N-terminal catalytic domain between 79-445
aa [43]. The dRP lyase activity of Polι is estimated to be⁓30-fold lower
than that of Polβ, the best known BER polymerase, however, the ratio
of dRP lyase to polymerase activity in Polι is much higher than for Polβ
[43]. Participation of Polι in BER using its dRP lyase and polymerase
enzymatic activities has been conﬁrmed using in vitro reconstitution
reactions involving puriﬁed uracil-DNA glycosylase, apurinic/apyr-
imidinic (AP) endonuclease, DNA ligase I, and Polι to repair G·U and
A·U mispairs in DNA, with similar average error rates observed for Polι
and Polβ [63]. Additionally, in the in vitro single-nucleotide BER Polι
has complemented deﬁciency of Polβ [43] and BER activity was re-
duced in extracts from cells downregulating Polι [64]. In contrast,
Haracska et al. proposed that binding of Polι and other Y-family poly-
merases to 5′-dRP groups acts as a covalent trap of these polymerases,
thus excluding their participation in DNA synthesis during BER [65].
Interestingly, Polι cannot fully complement Polβ deﬁciencies in vivo, as
Polβ-deﬁcient mice are not viable [66].
6. DNA lesions bypassed by Polι
The ability of Polι to synthesize DNA using substrates containing
variety of lesions has been extensively examined in vitro. While Polι can
incorporate deoxynucleotides opposite many lesions, it is generally
unable to extend resulting products, thus the bypass of these lesions
often requires the combined action of Polι and Polζ, Polκ, or Polθ
[4,22,67–69].
Abasic (apurinic/apyrimidinic, or AP) sites are frequently occurring
and highly mutagenic DNA lesions that can form spontaneously or as
intermediates of BER. Replicative DNA polymerases can ineﬃciently
bypass these lesions, preferentially inserting A opposite them. In con-
trast, Polι does not follow this “A-rule” and eﬃciently incorporates 1 nt,
typically either a G or T, in a unique mechanism [3,4,70–72] that is
signiﬁcantly stimulated by the presence of Mn2+ [57].
UV-irradiation induces a variety of potentially mutagenic DNA le-
sions of which cis-syn cyclobutane pyrimidine dimers (CPDs) and 6-4
pyrimidine photoproducts (6-4PPs) are the most abundant. CPD, the
most common UV lesion, is eﬃciently and accurately bypassed by Polη,
while conﬂicting data exist regarding CPD bypass by Polι. In contrast to
Fig. 2. Domains of Polι. The polymerase catalytic domain is contained within
the palm, ﬁngers, thumb, and little ﬁnger domains (diﬀerent shades of blue)
and partially overlaps with the dRP lyase domain (gray dotted lines). In addi-
tion, Polι contains a variety of domains involved in protein-protein interactions
and nuclear localization signal (NLS).
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Polη, in vitro experiments indicate that Polι generally has diﬃculty
bypassing CPDs [4,70]. However, extended incubation times and excess
amounts of enzyme allow for insertion of 1 or 2 nucleotides opposite
the lesion by Polι, with misincorporation rates 150-300-fold higher than
that for Polη [73]. Additionally, a stimulatory eﬀect on Polι by Mn2+ of
almost 25-fold in bypassing CPDs has been reported [57]. The second
most frequent UV lesion, 6-4PP is less problematic for Polι despite its
structurally distorting eﬀects. Opposite a 3′T of this lesion, Polι eﬃ-
ciently inserts all four types of nucleotides, with a preference for correct
A residues [4,73]. Opposite a 5′T, Polι preferably inserts G, especially if
A was incorporated opposite the 3′T [73]. However, Polι cannot extend
past a 6-4PP lesion, and TLS is completed in cooperation with Polζ
[4,73]. Interestingly, it seems that the sequence context of both UV
lesions has a strong impact on the eﬃciency of their bypass by Polι
[22,74].
Polι is also able to bypass one of the most abundant and mutagenic
oxidative lesions in DNA, 8-oxoguanine (8-oxoG). In fact, Polι exhibits
the highest ﬁdelity among all Y-family polymerases when bypassing 8-
oxoG, as it predominantly incorporates correct C or, to a lesser extent,
G. However, the eﬃciency of an 8-oxoG bypass is lower than Polι ef-
ﬁciency opposite undamaged G and lower than for other Y family
polymerases and Polβ [70,75–76]. Crystal structure analysis has re-
vealed that the preferable incorporation of correct C opposite 8-oxoG
lesions is a consequence of Hoogsteen bonding [77]. Additionally,
PCNA stimulates C incorporation opposite 8-oxoG lesions [78]. While
bypassing the oxidative lesions 5-hydroxycytosine and 5-hydroxyuracil,
both stable products of cytosine oxidation, Polι preferentially in-
corporates a correct G opposite 5-hydroxycytosine and an incorrect T
opposite 5-hydroxyuracil [75].
Uracil can be mistakenly incorporated into DNA or generated from
cytosine deamination and is a common DNA lesion estimated to occur
at a rate 70-200 events per day per cell [79]. It is normally faithfully
repaired by BER, however, when uracil generation escapes repair and
remains in DNA, it is highly mutagenic. Uracil is a non-blocking lesion
and can be bypassed by most polymerases through incorporation of A
opposite U. When uracil is generated by cytosine deamination, this
incorporation thus results in a C→T transition [80]. Polι, however, in-
corporates G and T opposite U more eﬃciently than A. T mis-
incorporation results in poor extension while G incorporation allow for
eﬃcient extension, consequently providing error-free bypass of uracil
derived from deaminated cytosine [75]. Alternatively, the inaccurate
incorporation of G opposite T by Polι may be beneﬁcial for genome
stability maintenance when T is a product of 5-methyl-cytosine dea-
mination [81].
Alkylating agents, which are common reactive chemicals of en-
vironmental and cellular origin, can generate a variety of DNA lesions
by alkylating ring nitrogens and extracyclic oxygen in DNA bases. The
lesion 1-methyl-adenine is highly cytotoxic and forms in DNA through
reactions with SN2 methylating agents like methyl methanesulfonate
(MMS). This methylation hampers formation of Watson-Crick pairs and
strongly blocks replicases. Both Polι and Polη can faithfully bypass these
lesions, resulting in 1% mutation rates, although Polι requires the ac-
tion of Polθ to extend DNA synthesis after incorporation of a nucleotide
opposite the lesion by Polι [69]. Steady state kinetic and structural
studies show that Polι most eﬃciently incorporates a T opposite this
lesion [82].
Another DNA lesion commonly formed upon treatment with many
methylating agents is 3-methyl-adenine, which obstructs replicase in-
teraction with the minor groove of DNA. Polι, similar to Polη, in-
corporates T opposite 3-methyl-adenine, although this incorporation
occurs with reduced eﬃciency compared to that opposite undamaged
template A and the strand cannot be eﬃciently extended by Polι
[83–84]. Opposite 3-methyl-cytosine, Polι preferentially mis-
incorporates T [85]. In addition, Polι can introduce nucleotides oppo-
site the poorly repairable lesions O2-alkyl-thymidines and O4-alkyl-
thymidines but cannot extend beyond them [86–87]. O6-methyl-
guanine is one of the most mutagenic lesions induced by DNA-alky-
lating agents, including endogenous compounds. Polι shows a strong
preference for T incorporation opposite this lesion (10-fold higher than
C) [88] due to Hoogsteen bonding, as revealed by crystal structure
analysis [89]. Similarly, opposite the O6-adduct O6-carbox-
ymethylguanine, Polι preferentially incorporates T, but is ineﬀective in
extending the resulting mismatch [90].
Despite the fact that many polymerases contain a single residue in
their active sites that functions as a steric gate to prevent the in-
corporation of NTPs into DNA, ribonucleotides can be incorporated into
DNA and are common lesions. For Polι, Y39 functions as a steric gate
and is conserved throughout the Y family of polymerases [91]. Inter-
estingly, the Y39A mutation, while reducing sugar discrimination, in-
creases base selectivity. The eﬃciency of NTP incorporation by wild
type Polι is about 1000 times lower than for dNTPs and extension after
NTP incorporation is only eﬃcient in the presence of accessible dNTPs.
Additionally, in contrast to its paralogue, Polη, Polι can also place ri-
bonucleotides opposite DNA lesions like abasic sites or 8-oxoG [91].
Polι also has the ability to incorporate nucleotides opposite bulky
DNA lesions, like 2-acetylaminoﬂuorene (AAF) adducts, that block
many other polymerases. Opposite AAF-adducted G, Polι accurately
inserts C [70].
Diol epoxides, such as benzo[a]pyrene diol epoxides (BPDEs), are
polycyclic aromatic hydrocarbon metabolites present as common,
highly mutagenic, and carcinogenic environmental pollutants. Bulky
adducts like dG-BPDE and dA-BPDE are not eﬃciently bypassed by Polι,
even when acting in combination with Polζ [92]. However, within a
variety of sequence contexts, dA-BPDE can be eﬃciently bypassed
through Polι incorporation of T followed by elongation by Polκ [93].
Similarly, Polκ assists in replication past 4-hydroxyequilenin after in-
corporation of T by Polι opposite the lesion [94].
The minor groove atom N2 of G is highly reactive and can conjugate
with diﬀerent sizes and types of adducts, including those induced by
potential carcinogens [13]. It has been proposed that Polι is able to
synthesize DNA using templates containing minor groove adducts due
to its unique Hoogsteen base-pairing ability followed by extension of
nascent DNA by Polκ [39,95–98]. However, Polι also appears capable of
performing extension after initial incorporation of C opposite N2-ethyl-
guanine [99]. The catalytic eﬃciency of Polι in bypassing minor groove
adducts depends on adduct hydrophobicity and bulkiness [100]. Primer
extension assays and shuttle vector technology demonstrated that Polι
preferentially inserts C opposite to N2-substituted-guanine lesions,
conﬁrming its accuracy and eﬃciency in bypassing minor groove N2-
guanine adducts [101,102].
The results of in vitro TLS experiments have shown that Polι is also
able to incorporate nucleotides opposite several other DNA lesions,
including 1,N2-etheno(ε)guanine (incorporates T and C) [103], 1,N-
ethenodeoxynosine [104], heptanone-etheno-cytosine (incorporates T)
[105], 3-(20-deoxy-β-D-erythro-pentofuranosyl)pyrimido-[1,2-a]purin-
10(3 H)-one (incorporates C) [106], N(oxypropenyl)-2’-deoxyadenosine
(incorporates T and C) [107], and 8,5’-cyclo-2’deoxyadenosine and
8,5’-cyclo-2’-deoxyguanosine tandem lesions [108]. Polι can also by-
pass N-deozyguanosin-8-yl-1-aminopyrene resulting from reaction with
the mutagen and the potential carcinogen 1-nitropyrene; however,
based on its eﬃciency and ﬁdelity, it is not the polymerase of choice
[109–110]. Interestingly, Polι can process DNA duplexes with breaks of
diﬀerent sizes and clustered DNA lesions containing AP sites and 5-
formyl-uracil [111].
The repair of intra- and intercrosslinks (ICLs) induced by many
cancer therapeutics like cisplatin and mitomycin C requires the co-
ordinated action of various repair mechanisms and TLS [112]. Polι does
not appear to be the main TLS polymerase involved in ICL repair and
contradicting results have been obtained regarding its ability to bypass
cisplatin-triggered major groove intrastrand guanine adducts
[113–115]. However, Polι faithfully incorporates C opposite acrolein-
mediated minor groove ICLs [116] and, through sequential action with
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Polκ, promotes the bypass of psoralen-induced ICL [117]. Moreover,
participation of Polι and other polymerases in bypassing DNA-peptide
cross-links has been shown [118].
A brief summary of the major DNA lesions bypassed by Polι and the
nucleotide preferably incorporated opposite each particular lesion is
presented in Table 1. A detailed summary and veriﬁcation of Polι in
vitro translesion synthesis with sequence context consideration is pre-
sented by Vaisman et al. [22]. Additionally, it is worth noting that the
published results on Polι bypass of various substrates often diﬀers be-
tween groups due to diﬀerences in reaction conditions, such as varia-
tions in salt concentration or divalent cation choice for in vitro reac-
tions.
Compared to the elaborate in vitro analysis of Polι incorporation of
nucleotides opposite a variety of DNA lesions, much less is known about
Polι participation in DNA lesion bypass in vivo and available results are
often inconsistent due diﬀerences in cellular backgrounds, systems, and
conditions. In addition, it must be remembered that contradictory re-
sults exist regarding Polι activity in cells from 129-derived mouse
strains, which are frequently used as models for investigating the
physiological functions of Polι [119–121]. Analysis of mice carrying
defective Polι showed unchanged mutagenesis levels and mutational
spectra compared to the wild type mice [122]. Moreover, Okhumo et al.
reported that a lack of Polι protein has no eﬀect on the UV sensitivity of
murine ﬁbroblasts, even in a Polη-deﬁcient background [32], while
Dumstorf et al. noticed a small but statistically signiﬁcant increase in
the UV-sensitivity of mouse primary ﬁbroblasts lacking Polι, regardless
of the presence of Polη [123]. Gueranger et al. reported enhanced UV
sensitivity in type I Burkitt’s lymphoma BL2 cell lines deprived of both
Polη and Polι compared to the POLH-/- clone; yet, POLI-/- UV sensitivity
was similar to that of wild type cells [124]. Similar results were also
observed for human ﬁbroblasts with Polι downregulation [64] and for
Polι-deﬁcient mouse embryonic ﬁbroblasts (MEFs) [125]. Jansen et al.
compared the UV sensitivity of MEFs deﬁcient in Polη, Polι, or Polκ, or
with a combination of double and triple deﬁciencies and suggested that
Polι only functions to a minor extent as a backup for Polη in bypassing
photolesions [126].
Diﬀering results have also been described regarding UV-induced
mutagenesis. Analysis of mutational spectra in supF and lacZ’ genes in
Polι-deﬁcient cells suggests that Polι does not play a signiﬁcant role in
UV lesion bypass and UV-induced mutagenesis [124,127]. However,
several other lines of evidence imply engagement of Polι in TLS past UV
lesions in mammalian cells. First, Dumstorf et al. observed suppression
of increases in UV-induced mutagenesis due to Polι inactivation at the
endogenous Hprt locus regardless of Polη activity, suggesting partici-
pation of Polι in the mutagenic bypass of UV photoproducts [123]. Si-
milarly, error-prone participation of Polι in TLS past UV lesions in the
absence of Polη is suggested by results from the study by Kanao et al.,
who observed alleviation of UV-induced mutation frequency in Polη/
Polι deﬁcient mice compared to Polη-deﬁcient mice [128]. Moreover,
mutation levels in XPV cells devoid of Polη tightly correlate with the
levels of Polι expression [129]. In addition, despite the fact that Polι
inactivation alone does not promote skin tumor development, Polι
protein may function to suppress UV-induced tumor development in
Polη-deﬁcient backgrounds. UV-induced skin tumors in Polη- and Polι-
deﬁcient mice developed 4 weeks earlier than in mice lacking only Polη
and a lack of Polι stimulates UV-induced mesenchymal carcinogenesis
[123,32]. In summary, most studies, even those using diﬀerent strate-
gies, indicate a role for Polι in the bypass of UV-induced lesions,
especially in the absence of Polη.
The expression of human Polι in yeast mutants that are highly
sensitive to alkylating agents, like Δmag1 Δrad30 and Δmag1 Δrad30
Δrev3, displayed enhanced resistance to MMS, suggesting that Polι can
replicate DNA past 3-methyl-adenine lesions [130,83]. However, a lack
of Polι in Polβ-deﬁcient mouse ﬁbroblast cells hardly had any eﬀect on
MMS sensitivity, compared to cells only deﬁcient in Polβ [131]. Ad-
ditionally, human ﬁbroblast cell lines showing Polι downregulation and
wild-type cells show similar sensitivities to ethyl methanesulfonate
(EMS) [64]. Nonetheless, embryonic ﬁbroblasts derived from Polι
knock-out mice show three times higher sensitivity to MMS compared
to wild-type cells [132]. Moreover, Yoon et al. showed that in human
cells, TLS opposite 3-methyl-adenine seems to occur in a highly error-
free manner compared to TLS in vitro experiments and, in one of the
pathways involved, Polι functions with Polκ to perform TLS [84]. Many
alkylating agents also react with N2 of guanine to form an array of N2-
alkyl-lesions like N2-methyl-guanine, N2-ethyl-guanine, and N2-propyl-
guanine, which can be bypassed by Polι either alone or with Polκ or
Polζ [133].
Interestingly, in human ﬁbroblasts with signiﬁcantly reduced Polι
expression mediated by RNA interference, increased sensitivity to oxi-
dative stress caused by hydrogen peroxide or menadione was not af-
fected by Polβ downregulation, but could be reversed by ectopic ex-
pression of Polι. Moreover, exposure of Polι-deﬁcient cells to oxidants
caused problems with S phase entrance, causing accumulation of G1
phase cells [64]. In addition, increased sensitivity to the oxidative agent
potassium bromide has been shown in human embryonic ﬁbroblasts
lacking Polι [132]. Furthermore, 4-hydroxynonenal, generated by
polyunsaturated fatty acid peroxidation and endogenous stress,
strongly sensitizes Polι-deﬁcient MEFs, suggesting that Polι is important
for the eﬃcient bypass of 4-hydroxynonenal-induced lesions [134].
7. Regulation of Polι levels and activity
Sabbioneda et al. estimated that only a small fraction of Polι is
engaged in TLS at the same time [135]. During the G2-M-G1 phases of
the cell cycle, Polι is equally distributed throughout the nucleus; how-
ever, during the S phase, it localizes to microscopically visible sub-
nuclear replication foci where replication-associated factors are con-
centrated [25]. However, TLS polymerases can also be recruited to
replication factories without the formation of observable foci, and
formation of foci does not guarantee that a protein is permanently
bound to DNA [124]. Similar to Polη, Polι transiently binds DNA for a
duration of 100-200ms. The mobility of Polη and Polι is slightly re-
duced in replication foci and formation of Polι foci seems to depend
signiﬁcantly, but not entirely, on the presence of Polη [135,25]. UV
radiation, but not MMS treatment or γ-irradiation, stimulates Polι foci
accumulation; however, UV-dependent Polι foci induction is not asso-
ciated with increased Polι expression [25].
In various types of tissues, Polι is generally expressed at low or
medium levels and DNA damage-induced expression of Polι is not ob-
served in normal cells. In contrast, there have been several reports
describing transcriptional regulation of Polι in cancer cells. Signiﬁcant
increases in Polι expression occur in cancer cells during hypoxia [136].
In contrast to other TLS polymerases such as Polη, Polκ, and Polμ, in-
duction of Polι transcription is dependent on the hypoxia-inducible
Table 1
Major DNA lesions bypassed by Polι
DNA lesion Preferred
nucleotide
Reference
Abasic site G [4,70,72]
6-4PP [4,73]
3′T A
5′T G
8-oxoG C [70,75]
U G [75]
G-AAF C [70]
1-methyl-A T [69]
3-methyl-A T [83,84]
3-methyl-C T [85]
O6-methyl-G T [88]
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factor HIF-1α. HIF-1α, together with the constitutively expressed HIF-
1β subunit, form the heterodimer HIF-1, a master player in an adaptive
strategy to hypoxia that enhances the expression of POLI gene by
binding the hypoxia response element (HRE) site at +330 bases in
intron 1 of POLI [136]. Moreover, analysis of the POLI promoter re-
vealed a cis-acting element between -1631 and -794 and the Sp1 tran-
scription factor was shown to bind between -1291 and -1081, resulting
in four-fold increased POLI expression in esophageal cancer tissues
compared to normal tissues [35]. Furthermore, Yuan et al. localized a
putative AP-1 binding cis-element within a minimal promoter (-275/
+63) at the -228 site and showed that c-Jun, which plays a central role
in AP-1 complex function, can activate transcription of POLI gene using
this AP-1 cis-element [137]. Interestingly, the c-Jun-dependent dysre-
gulation of POLI expression is also observable in bladder cancer cells
[137].
Despite the presence of CpG islands near the transcription start site
of POLI, which suggests that POLI transcriptional regulation potentially
occurs through DNA methylation, analysis of increased POLI expression
in esophageal cancer tissues indicates that epigenetic regulation is not
likely to be involved in POLI transcription regulation [35].
Unexpectedly, the activity of Polι and other Y family polymerases,
but not A, B, or X family polymerases, is stimulated by the biologically
active sphingolipids sphingosine and dihydrosphingosine, which play
roles in controlling cell proliferation via cell signaling [138].
8. Interacting partners and their inﬂuence on Polι function
The C-terminal half of Polι is rich in protein-protein interaction
domains that regulate the recruitment of Polι to the replication fork and
inﬂuence its function. However, it seems more likely that Polι tran-
siently interacts with its binding partners rather than forming stable
complexes. Similar to other Y-family polymerases, Polι physically in-
teracts with PCNA, which acts with replication factor (RFC) and re-
plication protein (RPA) to stimulate Polι polymerase activity, although
this does not aﬀect Polι ﬁdelity [139]. Polι interacts with PCNA through
the single PIP box located in the center of Polι immediately downstream
of the LF domain. Similar to other PCNA-interacting proteins, such as
Polδ or p21, Polι binds PCNA at the PCNA interdomain connector loop
(IDCL) [46–47]. It appears that the interaction of Polι and PCNA sti-
mulates DNA synthesis by Polι in a PIP-dependent manner and controls
localization of Polι to cellular replication machinery and accumulation
at sites of DNA damage [46]. The interaction through the PIP box of
Polι, is rather weak, as it is for other Y-family polymerases, and PCNA-
Polι interaction can be signiﬁcantly strengthened through PCNA
monoubiquitination, which forms an additional surface for interaction.
All four Y-family polymerases have one or two ubiquitin binding do-
mains that non-covalently bind ubiquitin and ubiquitinated proteins
like monoubiquitinated PCNA. Polι has two functional ubiquitin
binding motifs, UBM1 and UBM2, and the accumulation of Polι in re-
plication foci depends on its ability to bind ubiquitin [49–50]. Both
UBMs are required for proper recruitment of Polι to replication foci
[140] and the conserved UBM motif containing leucine and proline
plays an important role in ubiquitin binding. Interestingly, while most
known UBDs require the presence of conserved I44 in the hydrophobic
patch of ubiquitin for binding, Polι instead requires L8 in ubiquitin
[49,141]. Additionally, Polι can interact both with monoubiquitin and
K63-linked polyubiquitin chains while contradictory results have been
reported regarding binding of K48-linked ubiquitin chains [50,142].
Moreover, in contrast to Polη and Polκ, Polι does not promote the
monoubiquitination of PCNA [143].
Polι is known to interact physically and functionally with the Y
family polymerases Rev1 and Polη. Rev1 forms a scaﬀold for other TLS
polymerases at stalled replication forks and assists in polymerase
switching [11] through interaction of its approximately 100 amino acid
C-terminal domain (CTD) with special domains located in the other
polymerases [144–145]. Polι, Polη, and Polκ have short RIRs containing
two consecutive, centrally located, conserved phenylalanine residues
critical for interaction with Rev1-CTD [48]. The signiﬁcance of another
RIR helix residue highly conserved in vertebrates, K550, is uncertain
due to inconsistent results [146–147]. Interaction of Rev1 with Polι
appears to be much weaker than with Polη or Polκ [148] and the re-
quirement of Rev1 for subcellular localization of Polι and other Y-fa-
mily polymerases in response to DNA damage is disputable [46,149].
Based on results of co-localization studies, yeast two hybrid assays,
and in vitro experiments, Kannouche et al. suggest that Polι directly
interacts with Polη and that the last 224 amino acids of Polι and the last
119 amino acids of Polη (595-713 aa), which contain a nuclear locali-
zation signal, ubiquitin-binding domain (UBZ), and a PCNA-interacting
peptide, are suﬃcient for this association [25]. Later experiments
conﬁrmed that the UBZ and UBMs of both polymerases are required for
Polη and Polι interaction, however, the polymerases do not associate
directly through their UBDs and, but interact in a ubiquitin-mediated
manner [150]. Due to the potential for ubiquitination of both poly-
merases, the physical interaction between them can occur via the ubi-
quitinated form of either polymerase and the UBD of the interaction
partner [150]. In response to DNA damage, the localization of both
polymerases in replication foci is identical and in XPV cells lacking
Polη, the number of UV-induced Polι foci drops several times. It was
therefore proposed that Polη is involved in recruiting Polι to replication
machinery stalled at DNA damage sites [25]. However, analysis of re-
plication foci kinetics of both polymerases suggests that Polι dissociates
from replication foci more rapidly than Polη and that interactions be-
tween the two polymerases are rather transient or unstable [135].
Additionally, Petta et al. showed that Polι localization after laser-irra-
diation, which produces single- and double strand breaks and base
damage, was unaltered in XPV cells, suggesting that Polη is not required
for Polι accumulation at the site of DNA lesions [64].
Polι also associates with several other proteins, including XRCC1,
p53, and p300 during diﬀerent processes [64,151–152]. DNA repair
protein XRCC1 is a molecular scaﬀold protein that interacts with many
proteins involved in BER. Polι associates with XRCC1 and is recruited
with XRCC1 and another BER enzyme, Flap Endonuclease 1 (FEN1), to
chromatin in response to hydrogen peroxide treatment in human cells
[64].
Polι also physically and functionally interacts with p53, the tumor
suppressor that, in addition to its role in transcriptional regulation,
possesses intrinsic 3′→5′ exonuclease activity. The p53/Polι complex is
proposed to transiently stabilize lesion-blocked replication forks by
idling, which may lead to either a successful DNA damage bypass or
stimulate recombination events [151].
p300 is an acetyltransferase responsible for acetylation of histones
and hundreds of non-histone proteins. Additionally, it possesses a non-
canonical but functional RING domain characteristic of ubiquitin li-
gases. Besides acetylating and ubiquitinating proteins, p300 inﬂuences
multiple cellular processes through interactions with over 400 proteins.
Polι interacts with p300 and can also be acetylated by this enzyme. The
N-terminal region of Polι, containing its catalytic domain, interacts
with p300 in a manner that seems to require the acetyltransferase HAT
domain but not the RING domain of p300 [152].
9. Posttranslational modiﬁcations of Polι
Posttranslational modiﬁcations play a pivotal role in the regulation
of TLS proteins. Polι is known to be monoubiquitinated, poly-
ubiquitinated, and acetylated [49,152–153]. Monoubiquitination seems
to be a common Polι modiﬁcation, as it has been estimated that up to
20% of Polι is modiﬁed by attachment of a single ubiquitin to one of its
lysine residues under normal conditions [153]. In contrast to PCNA and
Polη, Polι does not seem to have a major ubiquitination site or even a
ubiquitination-dedicated region. Instead, mass spectrometry analysis
revealed 27 potential unique ubiquitination sites located in diﬀerent
functional domains of Polι, and mutation of K715 appears to yield the
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greatest reduction in Polι monoubiquitnation [14,153]. However, pos-
session of multiple possible ubiquitination sites does not mean that Polι
can be multi-monoubiquitinated, as it appears that monoubiquitinated
Polι cannot interact with free ubiquitin or other ubiquitinated proteins
[49,150]. So far, the only documented function of Polι mono-
ubiquitination is to facilitate its interaction with Polη [150].
In contrast to Polη, the monoubiquitination status of Polι does not
change in response to DNA damaging agents or general replication
blocks. However, exposure of cells to menadione and other structurally
related 1,4-naphthoquinones that inhibit p300 acetyltransferases, as
well as other structurally-unrelated p300 inhibitors, induces rapid Polι
polyubiquitination via attachment of K11- and K48-linked poly-
ubiquitin chains [153]. Furthermore, Polι can be directly acetylated by
p300/CBP acetyltransferases. Despite the fact that K550, located in the
RIR domain, has been identiﬁed as the main acetylation site, this
acetylation does not seem to interfere with interaction of Polι and Rev1.
Interestingly, acetylation of Polι is signiﬁcantly induced by alkylating
(particularly SN2 type) and oxidative agents. Importantly, this acet-
ylation seems to be speciﬁc for Polι, as its closest paralogue, Polη, is not
acetylated under similar conditions [152].
10. Possible cellular roles of Polι
The ability to incorporate nucleotides opposite a variety of lesions is
the most well recognized role of Polι in DNA damage tolerance during
replication. However, there is also evidence that Polι may process le-
sions in non-S phase cells. Sertic et al. demonstrated participation of
Polι and other Y-family polymerases in processing of UV-induced clo-
sely-spaced opposing lesions. Polymerases were recruited to sites of
local, NER-positive UV damage and Polι and Polκ accumulated at sites
only when the nuclease EXO1 was present. It has been suggested that
those Y-family polymerases partially help prevent unscheduled DNA
synthesis and double-strand breaks [154].
Moreover, because of its inﬁdelity and speciﬁc misincorporation
pattern, it has often been suggested that Polι may play a role in somatic
hypermutation (SHM) of immunoglobulin genes, a process involved in
generating antibody variation and in which Polι’s error-prone activity
would be an advantage [113,155]. Polι, Polκ, Polζ, and Rev1 mRNA is
present in normal human B cells and in Burkitt’s lymphoma BL2 cell
line containing an inducible IgV(H) gene. Out of all of these poly-
merases, however, Polι showed the highest level of expression (4-fold
increase), within 12 h of induction, implying that Polι may be one of
main polymerases responsible for SHM [156]. Additionally, fewer
mutations were observed in the BL2 line lacking the POLI gene com-
pared to the line with restored Polι, suggesting the dependence of SHM
on Polι [157]. However, an analysis of mutations in variable genes in
Polι-deﬁcient mice indicates no diﬀerences in the frequency and spec-
trum of mutations compared to wild type mice, suggesting that Polι
does not participate in SHM or that its role is nonessential and can be
performed by another polymerase [158–161]. In addition, Ratnam et al.
suggested that Polι may play a role in SHM in cells lacking p53 [162].
Maul et al., based on tandem mutation analysis, proposed a model in
which Polι occasionally accesses the replication fork and introduces
erroneously one nucleotide, with mismatch extension occurring
through a second mutation generated by Polζ [122].
11. Misregulation, genomic instability, and cancer
Genome instability is a common feature of tumor cells. Numerous
lines of evidence indicate that the function and regulation of Polι diﬀers
between cancerous cells and normal cells, implying that Polι is highly
regulated in normal cells but once it escapes from this precise regula-
tion, can be a potential mutator. This was ﬁrst suggested based on re-
sults linking Polι misregulation with the hypermutation status of breast
cancer cells [33]. Polι expression is increased at both the RNA and
protein levels in malignant breast cancer cell lines compared to non-
malignant tissues and this elevated expression correlates with enhanced
DNA replication inﬁdelity. Interestingly, in response to UV treatment,
Polι expression in breast cell lines, particularly in malignant cell lines,
was 2-7 times higher within 0.5-2 hours after treatment, suggesting the
existence of an early response to UV-mediated DNA damage. In addi-
tion, the enhanced level of UV-induced mutations, which consisted of
point mutations in> 90% of cases, is Polι-dependent [33]. Polι upre-
gulation has also been observed in a number of glioma specimens and
its levels are correlated with poor clinical outcomes [163]. Moreover, in
cells from high-grade invasive bladder tumors, elevations in Polι level
are dependent on the activated JNK/c-Jun pathway and are associated
with increased mutation frequency [137]. In contrast, the analysis of
over one hundred paired specimens of cancerous and non-malignant
samples revealed the downregulation of Polι, Polκ, Polζ and, in many
cases, Polη in human lung, stomach, and colorectal cancers [34]. Ad-
ditionally, defects in Polι are linked to increased susceptibility to ur-
ethane or diethylnitrosamine-induced lung tumors [31,164]. Interest-
ingly, the examination of Polι expression levels in 68 clinical cancer
specimens from kidney, breast, prostate, uterus, cervix, colon, lung,
stomach, or rectums compared to matched adjacent normal tissues re-
vealed over two-fold overexpression in 29% of tumor samples and less
than 0.5-fold reductions in expression in 20% of tumor samples [30].
These results thus indicate that both the upregulation and down-
regulation of Polι can be correlated with diﬀerent types of cancer, un-
derlining the necessity of the strict control of Polι protein levels.
Analysis of 24 normal esophageal tissue samples and 60 esophageal
squamous cell carcinoma (ESCC) samples revealed signiﬁcantly higher
levels of POLI mRNA (over 7-fold upregulation) in carcinoma tissues
compared to normal tissue [35]. Further analysis showed that esopha-
geal cancer cells overexpressing Polι are more invasive and in general
presented more aggressive phenotype coupled with poorer prognoses
[36,165]. In addition, invasion and metastasis of ESCC cells is activated
by Polι-dependent phosphorylation of Erk1/2, which in turn induces
phosphorylation of Y38 in the proto-oncogene ETS1/2, a key regulator
of cancer progression [166]. Similarly, results of studies of lung and
breast cancer cells also suggested a role of Polι in promoting cell mi-
gration and invasion via inﬂuence on expression of E- and N-cadherin
as well as MMP2 and MMP9, which are all proteins associated with
tumor cellular adhesion, motility, and other invasive properties
[167,168]. Additionally, enhanced expression of the POLI gene has also
been observed in some XPV tumor cells [169].
There is no known disorder resulting from Polι deﬁciencies, how-
ever, several Polι SNPs are correlated with certain cancers. I236M, lo-
cated in the thumb domain and aﬀecting ﬂuctuations in expression
levels, is linked to melanoma [170]. Furthermore, F507S, located in
UBM1, correlates with prostate cancer occurrence [171] while T706A,
located in UBM2, is associated with an increased risk of adenocarci-
noma and squamous cell carcinoma in lungs [172].
12. Biological consequences
People with altered Polι function, either through changes in ex-
pression level or genetic variations, exhibit no obvious health problems
despite individual risks of mutations and increased predisposition to
cancer via genotoxin exposure. Nonetheless, Polι may inﬂuence oc-
currence of poorer prognoses in the development of many cancers.
Additionally, due to its ability to bypass a variety of types of DNA le-
sions, one can imagine that Polι, similar to Polη and other TLS poly-
merases, may hamper the eﬀectiveness of anticancer therapies based on
introducing DNA damage or nucleoside analogs to actively dividing
tumor cells [112,173–174]. In addition, the pro-mutagenic eﬀects of
Polι and other Y family polymerases may cause acquisition of drug-
induced mutations related to treatment resistance by tumors, increased
risks of secondary malignancies, and cancer relapse. Additionally, the
activity of Polι and other non-canonical human polymerases also ap-
pears responsible for unwanted side eﬀects and drug toxicity of
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nucleoside reverse transcriptase inhibitors used in antiviral therapy
against HIV and hepatitis B [175–176]. Consequently, TLS polymerases
are promising new targets of improved cancer therapies or supple-
mentary therapies aiming to reduce chemotherapeutic resistance in
various tumors and unwanted cytotoxicity [177]. The unique properties
of TLS polymerases, including distinctive base pairing by Polι, increases
the chance of generating small molecule modulators speciﬁcally tar-
geting particular enzymes [178]. Related drug discovery eﬀorts are still
at their early stages; however, some results of investigations into TLS
polymerase inhibitors using natural compound and small molecule in-
hibitor screening and other approaches have been reported
[15,178–182].
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